These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Thomas M; Hayflick SJ; Jankovic J Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358 [TBL] [Abstract][Full Text] [Related]
5. [Studies on PANK2 gene mutations in Chinese patients with Hallervorden-Spatz syndrome]. Zhang Y; Tang B; Guo J; Long Z; Xia K; Pan Q; Hu Z; Wu D; Tang J; Chen T; Yan X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):189-91. PubMed ID: 15793782 [TBL] [Abstract][Full Text] [Related]
7. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings. Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850 [TBL] [Abstract][Full Text] [Related]
8. Pantothenate kinase-associated neurodegeneration: novel mutations in the PANK2 gene in an Argentinean young woman. Gatto E; Etcheverry JL; Converso DP; Bidinost C; Rosa A Mov Disord; 2010 Oct; 25(13):2262-4. PubMed ID: 20721927 [No Abstract] [Full Text] [Related]
9. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene. Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724 [TBL] [Abstract][Full Text] [Related]
10. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. Hayflick SJ; Westaway SK; Levinson B; Zhou B; Johnson MA; Ching KH; Gitschier J N Engl J Med; 2003 Jan; 348(1):33-40. PubMed ID: 12510040 [TBL] [Abstract][Full Text] [Related]
12. Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene. Cangül H; Ozdemir O; Yakut T; Okan M; Morgan NV; Baytan B; Kurian MA; Spiegel R; Maher ER Turk J Pediatr; 2009; 51(2):161-5. PubMed ID: 19480328 [TBL] [Abstract][Full Text] [Related]
13. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Zhou B; Westaway SK; Levinson B; Johnson MA; Gitschier J; Hayflick SJ Nat Genet; 2001 Aug; 28(4):345-9. PubMed ID: 11479594 [TBL] [Abstract][Full Text] [Related]
14. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model. Wu Z; Li C; Lv S; Zhou B Hum Mol Genet; 2009 Oct; 18(19):3659-72. PubMed ID: 19602483 [TBL] [Abstract][Full Text] [Related]
15. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Pellecchia MT; Valente EM; Cif L; Salvi S; Albanese A; Scarano V; Bonuccelli U; Bentivoglio AR; D'Amico A; Marelli C; Di Giorgio A; Coubes P; Barone P; Dallapiccola B Neurology; 2005 May; 64(10):1810-2. PubMed ID: 15911822 [TBL] [Abstract][Full Text] [Related]
16. Novel mutation in PANK2 associated with retinal telangiectasis. Sohn EH; Michaelides M; Bird AC; Roberts CJ; Moore AT; Smyth D; Brady AF; Hungerford JL Br J Ophthalmol; 2011 Jan; 95(1):149-50. PubMed ID: 20974629 [No Abstract] [Full Text] [Related]